IRIS
MANNI, ALESSIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 841
EU - Europa 190
AS - Asia 91
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 1
Totale 1.125
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 839
SE - Svezia 75
CN - Cina 58
IT - Italia 55
SG - Singapore 24
FI - Finlandia 16
DE - Germania 10
GB - Regno Unito 8
FR - Francia 7
BE - Belgio 6
VN - Vietnam 6
UA - Ucraina 4
CA - Canada 2
CZ - Repubblica Ceca 2
EU - Europa 2
HK - Hong Kong 2
AL - Albania 1
AU - Australia 1
BG - Bulgaria 1
IE - Irlanda 1
IN - India 1
IS - Islanda 1
MK - Macedonia 1
RO - Romania 1
RU - Federazione Russa 1
Totale 1.125
Salva come PNG Salva come JPEG
Città #
Fairfield 128
Chandler 118
Woodbridge 95
Ashburn 70
Nyköping 62
Houston 54
Seattle 50
Cambridge 44
Ann Arbor 29
Wilmington 28
Beijing 21
Singapore 19
Lawrence 16
Roxbury 14
Helsinki 12
Bari 11
Des Moines 9
Bisceglie 8
Munich 8
Inglewood 7
Jacksonville 7
Brooklyn 6
Brussels 6
Dong Ket 6
Los Angeles 6
Paris 6
Princeton 6
Gravina in Puglia 5
Shenyang 5
Boardman 4
New York 4
Norwalk 4
Santa Clara 4
Shanghai 4
Dearborn 3
Grottaglie 3
Guangzhou 3
Lviv 3
Nanjing 3
San Diego 3
Washington 3
Brno 2
Hebei 2
Hong Kong 2
Imbersago 2
Jesi 2
Jinhua 2
Milan 2
Tianjin 2
Chengdu 1
Chicago 1
Dalian 1
Dublin 1
Florence 1
Guiyang 1
Hamilton 1
Hangzhou 1
Hounslow 1
Jiaxing 1
Jinan 1
Kansas City 1
Keflavik 1
Kilburn 1
Leawood 1
Leninsk-kuznetskiy 1
Lilienthal 1
London 1
Melbourne 1
Middlesex 1
Mottola 1
Nantong 1
Ningbo 1
Phoenix 1
Pune 1
Quzhou 1
Redwood City 1
Santa Marinella 1
Shenzhen 1
Sofia 1
Taranto 1
Tirana 1
Torino 1
Toronto 1
Trani 1
Weifang 1
Wuhan 1
Totale 950
Salva come PNG Salva come JPEG
Nome #
Long-term cardiac safety and tolerability of fingolimod in multiple sclerosis: A postmarketing study 128
The cost of relapsing-remitting multiple sclerosis patients who develop neutralizing antibodies during interferon beta therapy 107
Gender differences in safety issues during Fingolimod therapy: Evidence from a real-life Relapsing Multiple Sclerosis cohort 106
Lymphocyte subsets as biomarkers of therapeutic response in Fingolimod treated Relapsing Multiple Sclerosis patients 105
Retrospectively acquired cohort study to evaluate the long-term impact of two different treatment strategies on disability outcomes in patients with relapsing multiple sclerosis (RE.LO.DI.MS): data from the Italian MS Register 94
Lymphocyte count and body mass index as biomarkers of early treatment response in a multiple sclerosis dimethyl fumarate-treated cohort 92
Development and validation of the ID-EC - The ITALIAN version of the identify chronic migraine 75
The role of neutralizing antibodies to interferon-β as a biomarker of persistent MRI activity in multiple sclerosis: a 7-year observational study 71
Durvalumab and multiple sclerosis: a causal link or simple unmasking? 51
null 44
Personalizing Cancer Pain Therapy: Insights from the Rational Use of Analgesics (RUA) Group 42
Defining the course of tumefactive multiple sclerosis: a large retrospective multicentre study 41
Magnetoencephalography and high‐density electroencephalography study of acoustic event related potentials in early stage of multiple sclerosis: A pilot study on cognitive impairment and fatigue 34
Effect of cladribine on neuronal apoptosis: New insight of in vitro study in multiple sclerosis therapy 33
Longitudinal Evaluation of Serum MOG-IgG and AQP4-IgG Antibodies in NMOSD by a Semiquantitative Ratiometric Method 33
Risk of Getting COVID-19 in People With Multiple Sclerosis 28
Efficacy and Safety of Oral Therapies for Relapsing-Remitting Multiple Sclerosis 23
Macular ganglion cell-inner plexiform layer defect patterns in multiple sclerosis patients without optic neuritis: A Spectral-Domain-Optical Coherence Tomography Cross-Sectional, Case-Control, Pilot Study 20
Conversion to secondary progressive multiple sclerosis: Patient awareness and needs. Results from an online survey in Italy and Germany 17
Real-Life Experience of the Effects of Cladribine Tablets on Lymphocyte Subsets and Serum Neurofilament Light Chain Levels in Relapsing Multiple Sclerosis Patients 15
A case report of late-onset atypical Hemolytic Uremic Syndrome during interferon beta in multiple sclerosis: Open issues in literature review 11
Neutralizing Antibodies and Multiple Sclerosis in the Era of Disease Modifying Treatments 10
Dancing With Parkinson's Disease: The SI-ROBOTICS Study Protocol 7
Impact of depression on the perception of fatigue and information processing speed in a cohort of multiple sclerosis patients 7
Clinical and biological predictors of Cladribine effectiveness in Multiple Sclerosis: A real-world, single Centre study considering a two-year interval from year-2 dosing 3
Multiple Sclerosis Progression and Relapse Activity in Children 3
Totale 1.200
Salva come PNG Salva come JPEG
Categoria #
all - tutte 6.844
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.844
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020230 0 0 4 12 30 18 29 35 30 27 36 9
2020/2021210 16 12 14 30 17 16 24 16 11 20 18 16
2021/2022144 13 4 2 5 8 19 5 9 9 12 25 33
2022/2023279 35 47 18 21 35 31 9 31 33 1 8 10
2023/2024111 18 17 3 16 15 15 3 6 1 7 0 10
2024/202580 34 4 42 0 0 0 0 0 0 0 0 0
Totale 1.200